[go: up one dir, main page]

AU2015293541B2 - Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof - Google Patents

Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof Download PDF

Info

Publication number
AU2015293541B2
AU2015293541B2 AU2015293541A AU2015293541A AU2015293541B2 AU 2015293541 B2 AU2015293541 B2 AU 2015293541B2 AU 2015293541 A AU2015293541 A AU 2015293541A AU 2015293541 A AU2015293541 A AU 2015293541A AU 2015293541 B2 AU2015293541 B2 AU 2015293541B2
Authority
AU
Australia
Prior art keywords
substituted phenyl
acid compounds
alkanoic acid
gpr120
gpr120 agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2015293541A
Other languages
English (en)
Other versions
AU2015293541A1 (en
Inventor
Vijaykumar Bhagwan Deore
Sanjay Kumar
Rajiv Sharma
Nilambari Nilkanth Yewalkar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Piramal Enterprises Ltd
Original Assignee
Piramal Enterprises Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Piramal Enterprises Ltd filed Critical Piramal Enterprises Ltd
Publication of AU2015293541A1 publication Critical patent/AU2015293541A1/en
Application granted granted Critical
Publication of AU2015293541B2 publication Critical patent/AU2015293541B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/46—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/20—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hydrogen atoms and substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D309/22—Radicals substituted by oxygen atoms
    • C07D309/24—Methylol radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/06—One of the condensed rings being a six-membered aromatic ring the other ring being four-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
    • C07C2602/28—Hydrogenated naphthalenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU2015293541A 2014-07-25 2015-07-23 Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof Ceased AU2015293541B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462028891P 2014-07-25 2014-07-25
US62/028,891 2014-07-25
PCT/IB2015/055572 WO2016012965A2 (fr) 2014-07-25 2015-07-23 Composés d'acide phénylalcanoïque substitué utilisables en tant qu'agonistes de gpr120 et leurs utilisations

Publications (2)

Publication Number Publication Date
AU2015293541A1 AU2015293541A1 (en) 2017-02-16
AU2015293541B2 true AU2015293541B2 (en) 2019-11-21

Family

ID=55163912

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015293541A Ceased AU2015293541B2 (en) 2014-07-25 2015-07-23 Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof

Country Status (7)

Country Link
US (1) US10273230B2 (fr)
EP (1) EP3172185B1 (fr)
AU (1) AU2015293541B2 (fr)
CA (1) CA2955919A1 (fr)
IL (1) IL250255B (fr)
WO (1) WO2016012965A2 (fr)
ZA (1) ZA201700629B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ721645A (en) 2014-02-19 2018-02-23 Piramal Entpr Ltd Compounds for use as gpr120 agonists
EP3191463B1 (fr) 2014-09-11 2019-10-30 Piramal Enterprises Limited Composés hétérocycliques condensés à titre d'agonistes du gpr120
EP3253745B1 (fr) 2015-02-05 2021-09-29 Piramal Enterprises Limited Composés contenant une séquence de liaison carbone-carbone en tant qu'agonistes gpr120
US10728113B2 (en) 2016-10-26 2020-07-28 Zscaler, Inc. Systems and methods for troubleshooting and performance analysis of cloud based services
US11811623B2 (en) 2016-10-26 2023-11-07 Zscaler, Inc. Deep tracing of user experience
WO2018107415A1 (fr) 2016-12-15 2018-06-21 Merck Sharp & Dohme Corp. Composés d'hydroxy isoxazole utiles en tant qu'agonistes de gpr120
US10357489B2 (en) 2017-07-10 2019-07-23 Celgene Corporation Antiproliferative compounds and methods of use thereof
WO2019171277A1 (fr) 2018-03-06 2019-09-12 Janssen Pharmaceutica Nv Dérivés de cylcoalcényle utiles en tant qu'agonistes des récepteurs gpr120 et/ou gpr40
US20210024483A1 (en) 2018-03-06 2021-01-28 Janssen Pharmaceutica Nv Heterocylcoalkenyl derivatives useful as agonists of the gpr120 and / or gpr40
PT3762368T (pt) 2018-03-08 2022-05-06 Incyte Corp Compostos de aminopirazina diol como inibidores de pi3k-y
EP3765446A1 (fr) 2018-03-15 2021-01-20 AXXAM S.p.A. Pyrazoles substitués agonistes du récepteur ffa4/gpr120
WO2020010003A1 (fr) 2018-07-02 2020-01-09 Incyte Corporation DÉRIVÉS D'AMINOPYRAZINE UTILISÉS EN TANT QU'INHIBITEURS DE PI3K-γ
US12137023B2 (en) 2019-02-25 2024-11-05 Zscaler, Inc. Automatic analysis of user experience issues to reduce resolution time
TW202237119A (zh) 2020-12-10 2022-10-01 美商住友製藥腫瘤公司 Ａｌｋ﹘５抑制劑和彼之用途
US11811633B2 (en) 2021-01-14 2023-11-07 Zscaler, Inc. Traceroutes through external proxies
US11758025B2 (en) 2021-01-14 2023-09-12 Zscaler, Inc. Adaptive tracing using one of a plurality of protocols
US11949578B2 (en) 2021-01-14 2024-04-02 Zscaler, Inc. Adaptive probing to discover a protocol for network tracing
US11863415B2 (en) 2021-01-14 2024-01-02 Zscaler, Inc. Determining endpoint and application behavior for monitoring user experience
US11425015B2 (en) 2021-01-14 2022-08-23 Zscaler, Inc. Accurate differential traceroute latency calculation between hops
US11671438B2 (en) 2021-01-14 2023-06-06 Zscaler, Inc. Detection of latency, packet drops, and network hops through a tunnel by tracing hops therein
US11770319B2 (en) 2021-01-14 2023-09-26 Zscaler, Inc. TCP traceroute using RST and SYN-ACK to determine destination reachability
US11637766B2 (en) 2021-01-14 2023-04-25 Zscaler, Inc. Detection of network hops and latency through an opaque tunnel and detection misconfiguration of tunnels
US11784904B2 (en) 2021-01-14 2023-10-10 Zscaler, Inc. Adaptive tracing with a reduced number of probes to avoid firewall issues
US11153190B1 (en) 2021-01-21 2021-10-19 Zscaler, Inc. Metric computation for traceroute probes using cached data to prevent a surge on destination servers
US11546240B2 (en) 2021-03-01 2023-01-03 Zscaler, Inc. Proactively detecting failure points in a network
US11563665B2 (en) 2021-03-05 2023-01-24 Zscaler, Inc. Detecting web probes versus regular traffic through a proxy including encrypted traffic
US12438785B2 (en) 2022-06-01 2025-10-07 Zscaler, Inc. Advanced machine learning techniques for internet outage detection
US12028237B2 (en) 2022-06-28 2024-07-02 Zscaler, Inc. Egress handling for networks with public internet protocol (IP) address

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789423A (en) * 1995-12-21 1998-08-04 Pfizer Inc. 3- 5-substituted benzyl)amino!-2-phenylpiperidines as substance P antagonists
WO2010048207A2 (fr) * 2008-10-21 2010-04-29 Metabolex, Inc. Agonistes de récepteur gpr120 aryl et utilisations de ceux-ci
WO2013185766A1 (fr) * 2012-06-15 2013-12-19 Syddansk Universitet Modulateurs du récepteur gpr120

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122317C (fr) 1961-07-19
FR1498700A (fr) 1965-10-04 1968-01-10
CA2547430A1 (fr) 2003-11-26 2005-06-09 Takeda Pharmaceutical Company Limited Agent de regulation de la fonction d'un recepteur
KR20070004769A (ko) 2004-02-27 2007-01-09 암젠 인코포레이션 대사 장애의 치료에 사용되는 화합물, 약제학적 조성물 및그 사용방법
EP2098517B1 (fr) 2006-12-01 2013-12-18 Msd K.K. Nouveau dérivé de phényl-isoxazol-3-ol
EA200901099A1 (ru) 2007-02-22 2010-04-30 Айрм Ллк Соединения и способы модулирования сопряженных с g-белком рецепторов
EA200901098A1 (ru) 2007-02-22 2010-04-30 Айрм Ллк Производные тиазола в качестве модуляторов сопряженных с g-белком рецепторов
WO2009038204A1 (fr) 2007-09-17 2009-03-26 Pharma Frontier Co., Ltd. Nouveau composé dérivé d'un acide gras à longue chaîne et agoniste des récepteurs couplés aux protéines g qui contient le composé en tant qu'ingrédient actif
EP2684861A3 (fr) 2007-10-26 2014-05-07 Japan Tobacco Inc. Composés spiro et leur utilisation pharmaceutique
CA2725316A1 (fr) 2008-06-02 2009-12-10 Banyu Pharmaceutical Co., Ltd. Nouveau derive d'isoxazole
EP2300442A2 (fr) 2008-06-24 2011-03-30 Irm Llc Composés et procédés pour moduler les récepteurs couplés à la protéine g
AR074760A1 (es) 2008-12-18 2011-02-09 Metabolex Inc Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
WO2010104195A1 (fr) 2009-03-11 2010-09-16 Banyu Pharmaceutical Co.,Ltd. Nouveau dérivé d'isoindolin-1-one
DE102009033208A1 (de) 2009-07-15 2011-01-20 Merck Patent Gmbh Aminopyridinderivate
WO2011072132A1 (fr) 2009-12-09 2011-06-16 The Regents Of The University Of California Procédés de traitement d'états inflammatoires
JP5746334B2 (ja) 2010-06-16 2015-07-08 シマベイ セラピューティクス， インコーポレーテッド Ｇｐｒ１２０受容体作動薬及びその使用
US8299117B2 (en) 2010-06-16 2012-10-30 Metabolex Inc. GPR120 receptor agonists and uses thereof
ES2829388T3 (es) 2010-10-30 2021-05-31 Kindex Therapeutics Llc Derivados de cis 3,4-dihidroxi-2-(3-metilbutanoil)-5-(-3-metilbutil)-4-(4-metilpentanoil)cyclopent-2-en-1-ona, composiciones sustancialmente puras enantioméricamente y métodos
WO2013128378A1 (fr) 2012-02-28 2013-09-06 Piramal Enterprises Limited Dérivés d'acide phénylalcanoïque en tant qu'agonistes du rpg
WO2013139341A1 (fr) 2012-03-20 2013-09-26 Syddansk Universitet Modulateurs de récepteurs gpr120
US20140069963A1 (en) 2012-09-07 2014-03-13 Jeffrey Stein Chilled Beverage Dispenser
WO2014059232A2 (fr) 2012-10-11 2014-04-17 Merck Sharp & Dohme Corp. Composés spiropipéridinyliques substitués utiles comme agonistes de gpr120
CN104046350B (zh) 2013-03-15 2018-08-17 广州熵能创新材料股份有限公司 一种荧光微球及制备方法和应用
NZ721645A (en) 2014-02-19 2018-02-23 Piramal Entpr Ltd Compounds for use as gpr120 agonists
WO2016022446A1 (fr) 2014-08-08 2016-02-11 Merck Sharp & Dohme Corp. Composés antidiabétiques bicycliques à fusion [5,6]
EP3191463B1 (fr) 2014-09-11 2019-10-30 Piramal Enterprises Limited Composés hétérocycliques condensés à titre d'agonistes du gpr120

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789423A (en) * 1995-12-21 1998-08-04 Pfizer Inc. 3- 5-substituted benzyl)amino!-2-phenylpiperidines as substance P antagonists
WO2010048207A2 (fr) * 2008-10-21 2010-04-29 Metabolex, Inc. Agonistes de récepteur gpr120 aryl et utilisations de ceux-ci
WO2013185766A1 (fr) * 2012-06-15 2013-12-19 Syddansk Universitet Modulateurs du récepteur gpr120

Non-Patent Citations (17)

* Cited by examiner, † Cited by third party
Title
"1 S-(exo,exo)]-2-[[3-[4-[[(4-cyclohexylbutyl)amino]carbonyl]-2-oxazolyl]-7- oxabicyclo[2.2.1]hept-2-yl]methoxy]-benzeneacetic acid", Registry, CAS, (1996-02-13), Database accession no. 173160-56-0, URL: STN *
"2-[[2-(7-amino-2-naphthalenyl)cyclopentyl]methoxy]-benzenepropanoic acid methyl ester", Registry, CAS, (2008-06-13), Database accession no. 1027894-93-4, URL: STN *
"2-[[2-(7-amino-2-naphthalenyl)cyclopentyl]methoxy]-benzenepropanoic acid", Registry, CAS, (2008-06-11), Database accession no. 1027427-54-8, URL: STN *
"2-[[2-[6-(carboxymethoxy)-2-naphthalenyl]cyclohexyl]methoxy]-benzenepropanoic acid", Registry, CAS, (2008-06-08), Database accession no. 1026475-19-3, URL: STN *
"3-(2-((2-(6-aminonaphthalen-2-yl)cyclopentyl)methoxy)phenyl)propanoic acid", Registry, CAS, (2008-06-06), Database accession no. 1025918-57-3, URL: STN *
"3,4-dihydro-7-[[[(3R,4R)-4-[4-[3-[(2-methoxyphenyl)methoxy]propoxy]phenyl]-3- piperidinyl]oxy]methyl]- 1(2H)-quinolineethanesulfonamide", Registry, CAS, (2011-12-01), Database accession no. 1346947-23-6, URL: STN *
"3-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-4-(2,2,2-trifluoroethoxy)- benzeneacetamide", CAS, (2011-12-02), Database accession no. 1347559-94-7, URL: STN *
"5-[[[2-(1H-imidazol-1-yl)cyclopentyl]amino]methyl]-2-thiopheneacetic acid", Registry, CAS, (2014-02-23), Database accession no. 1553145-75-7, URL: STN *
"6-[2-[[2-(2-carboxyethyl)phenoxy]methyl]cyclohexyl]-2-naphthalenecarboxylic acid", Registry, CAS, (2008-06-08), Database accession no. 1026500-58-2, URL: STN *
"6-[2-[[2-(3-methoxy-3-oxopropyl)phenoxy]methyl]cyclohexyl]-2- naphthalenecarboxylic acid", Registry, CAS, (2008-06-12), Database accession no. 1027654-19-8, URL: STN *
"methyl 3-(2-((2-(6-aminonaphthalen-2-yl)cyclopentyl)methoxy)phenyl)propanoate", Registry, CAS, (2008-06-08), Database accession no. 1026489-82-6, URL: STN *
"rel-3-[[[(2R,3 S)-2-(2-fluoro-5-methoxyphenyl)-6-oxo-3-piperidinyl]amino]methyl]- 1H- indole-1-acetamide", Registry, CAS, (2011-04-29), Database accession no. 1287459-87-3, URL: STN *
"rel-3-[[[(2R,3 S)-2-(2-fluoro-5-methoxyphenyl)-6-oxo-3-piperidinyl]amino]methyl]-1 H- indole-1-propanamide", Registry, CAS, (2011-04-29), Database accession no. 1287467-25-7, URL: STN *
GUDA MALLIKARJUNA REDDY, PUTTA RAMACHANDRA REDDY, VENKATAPURAM PADMAVATHI, ADIVIREDDY PADMAJA: "Synthesis and Antioxidant Activity of a New Class of Mono- and Bis-Heterocycles", ARCHIV DER PHARMAZIE, WILEY VERLAG, WEINHEIM, vol. 346, no. 2, 1 February 2013 (2013-02-01), Weinheim, pages 154 - 162, XP055387705, ISSN: 0365-6233, DOI: 10.1002/ardp.201200353 *
ILHAM MARHRAOUI, EL MESTAFA EL HADRAMI, ABDESLEM BEN-TAMA, MOHAMED EL ASRI: "Synthese de nouveaux glycosyl-1,2,3-triazoles 1,4- disubstitues", JOURNAL MAROCAIN DE CHIMIE HETEROCYCLIQUE, IMIST, MAROC, vol. 9, no. 1, 1 December 2010 (2010-12-01), MAROC, pages 59 - 67, XP008185394, ISSN: 1114-7792 *
PADMAJA, A. ET AL.: "Synthesis and antimicrobial activity of pyrrolyl/pyrazolyl arylaminosulfonylmethyl 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles", CHEM. PHARM. BULL., vol. 59, 1 January 2011 (2011-01-01), pages 1509 - 1517, XP003032451, DOI: 10.1248/cpb.59.1509 *
REDDY, G.M. ET AL.: "Synthesis and antioxidant activity of styrylsulfonylmethyl 1,3,4- oxadiazoles, pyrazolyl/isoxazolyl-1,3,4-oxadiazoles", CHEM. PHARM. BULL., vol. 61, 1 January 2013 (2013-01-01), pages 1291 - 1297, XP003032450 *

Also Published As

Publication number Publication date
EP3172185A2 (fr) 2017-05-31
US10273230B2 (en) 2019-04-30
WO2016012965A2 (fr) 2016-01-28
AU2015293541A1 (en) 2017-02-16
US20170210731A1 (en) 2017-07-27
IL250255A0 (en) 2017-03-30
EP3172185B1 (fr) 2020-03-04
ZA201700629B (en) 2021-08-25
IL250255B (en) 2020-11-30
WO2016012965A3 (fr) 2016-03-17
EP3172185A4 (fr) 2018-01-24
CA2955919A1 (fr) 2016-01-28

Similar Documents

Publication Publication Date Title
AU2015293541B2 (en) Substituted phenyl alkanoic acid compounds as GPR120 agonists and uses thereof
NZ721645A (en) Compounds for use as gpr120 agonists
EP4349840A3 (fr) Dérivé de pyrazolopyridine ayant un effet agoniste du récepteur glp-1
WO2015200481A8 (fr) Inhibiteurs de mnk et procédés associés
EP4071149A3 (fr) Composés hétérocycliques et leurs utilisations
TN2016000581A1 (en) Heteroaryl compounds useful as inhibitors of sumo activating enzyme
NZ729037A (en) Carboxylic acid compound, method for preparation thereof, and use thereof
MX373102B (es) Derivados radiomarcados de un compuesto de 2-amino-6-fluoro-n-[5-fluoro-piridin-3-il]-pirazolo[1,5-a]pirimidin-3-carboxamida útil como inhibidor de ataxia telangiectasia mutada y rad3 relacionado (atr) cinasa, preparación de tal compuesto y diferentes formas sólidas del mismo.
PH12016502034B1 (en) Pyrrolidine gpr40 modulators for the treatment of diseases such as diabetes
PH12017501160A1 (en) 5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as adamts inhibitors for the treatment of osteoarthritis
PH12016501517B1 (en) Tetrazolone-substituted dihydropyridinone mgat2 inhibitors
PH12016501462A1 (en) Neprilysin inhibitors
PH12016502246A1 (en) Carboxamide derivatives
MX2016010973A (es) Compuestos de aminocarbonilcarbamato.
WO2014159794A3 (fr) Modulateurs de récepteurs gpr120 à base d'acide bicyclo [2.2.1]
MX2016014946A (es) Derivados de carboxamida.
WO2016166720A3 (fr) Polymorphes et procédé pour la préparation de dérivés de quinazolinyle
WO2015191681A3 (fr) Pyridinones substituées utilisées comme inhibiteurs de mgat2
MX2016014118A (es) Moduladores de receptor de proteina g 40 (gpr40) de pirrolidina para tratamiento de enfermedades tales como diabetes.
MX2018015990A (es) Compuestos terapeuticos.
IN2014MU00072A (fr)
IN2013MU03670A (fr)
PH12016502247A1 (en) Carboxamide derivatives
HK1231074A1 (en) Neprilysin inhibitors

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired